Physician profile
Brian DO Tran
NPI 1902920796
$1,500.74
in general payments reported to CMS, 2019-2025
11 companies · $282 in 2025
The $282 reported for 2025 was more than what 88% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2022: $399 · 2023: $583 · 2024: $87.59 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $952.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $275.98 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Grifols USA, LLC | $274.56 | 2022-2023 | Hyperrab |
| Astrazeneca Pharmaceuticals Lp | $264.19 | 2023-2025 | Andexxa, Fasenra, Airsupra |
| Atricure, INC. | $136.01 | 2025 | Synergy Ablation System |
| Pfizer INC. | $131.76 | 2019 | |
| Abbvie INC. | $116.72 | 2023 | |
| Janssen Pharmaceuticals, INC | $110.05 | 2022 | |
| Becton, Dickinson and Company | $94.00 | 2022 | |
| Medtronic, INC. | $45.00 | 2022 | |
| Mindray Ds USA, INC. | $34.92 | 2023 | Te X, Te7 Max |
| Vapotherm INC | $17.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.